Unresolved Issues in the Comparison of Therapies and Determination of Responses in Waldenström Macroglobulinemia

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2010.509455
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Waldenström Macroglobulinemia

2020English

The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Predictors of Symptomatic Hyperviscosity in Waldenström Macroglobulinemia

American Journal of Hematology
Hematology
2018English

Waldenström Macroglobulinemia: Review of Pathogenesis and Management

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Profiling of Circulating Exosomal miRNAs in Patients With Waldenström Macroglobulinemia

PLoS ONE
Multidisciplinary
2018English

Ibrutinib Discontinuation in Waldenström Macroglobulinemia: Etiologies, Outcomes, and IgM Rebound

American Journal of Hematology
Hematology
2018English

CNS Vasculitis Associated With Waldenström Macroglobulinemia

Case Reports in Neurological Medicine
2016English

A 50-Year-Long Study of Waldenström Macroglobulinemia

Mayo Clinic Proceedings
Medicine
2019English

Waldenström Macroglobulinemia: 2018 Update on Diagnosis, Risk Stratification, and Management

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy